View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
December 17, 2020

Sheba, Iguazio to develop real-time AI to optimise patient care

Sheba Medical Center’s ARC innovation complex and technology company Iguazio have partnered to work on delivering a real-time AI to optimise patient care.

Sheba Medical Center’s ARC innovation complex and technology company Iguazio have partnered to work on delivering a real-time AI to optimise patient care.

Free Whitepaper
img

How is AI impacting the future of Healthcare?

The applications of AI in healthcare are many, with the potential to transform key aspects of the industry and drive innovation. Uses include data management, remote surgery, diagnostic and procedural AI assistants, drug discovery, and clinical trial design. GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019.

GlobalData’s AI in Healthcare Thematic Research report provides you with an in-depth lens into the impact of artificial intelligence on the industry. We highlight both the challenges and opportunities associated with the innovative technology now, and in the future. Our report also covers:

  • Major players and companies
  • Market size and growth forecasts
  • Case studies
  • Sector scorecard

According to our recent survey, almost two-thirds of pharma professionals expect AI to be the leading disruptive technology in the pharma sector over the next two years. With threats to the industry exacerbated by the COVID-19 pandemic, you should be proactive in adapting strategies and processes to help you remain competitive. Download the full report to get ahead of the competition.

by GlobalData
Enter your details here to receive your free Whitepaper.

Iguazio was selected to assist the digital transformation of Sheba with real-time AI and machine learning operations (MLOps) in several projects.

One of the projects that the companies are working is optimisation of patient care through clinical, real-time predictive data.

Sheba will use the Iguazio Data Science Platform to foresee and lessen complications in cases such as Covid-19 patient deterioration or support decision-making throughout surgery.

Iguazio co-founder and CEO Asaf Somekh said: “We are honoured to be supporting Sheba, a global leader in healthcare innovation, especially in the midst of the current pandemic, when the community is relying on health facilities the most.

“Incorporating AI into these many real-time use cases is setting a new standard for medical centres worldwide.”

In another project, AI will be used in the form of smart mobility to plan out the patient’s entire journey from arrival to the medical facility to departure following treatment.

It will also allow patient flow management and help comply with Covid-19 social distancing protocols.

Furthermore, the projects include collaboration on multi-cloud and hybrid deployments with Microsoft Azure and Google GCP.

Sheba chief medical officer and chief innovation officer Eyal Zimlichman MD said: “Bringing real-time AI to every aspect of Sheba’s emerging City of Health is the next step in our digital transformation.

“After months of perfecting our AI research across many use cases, it’s time to bring them to life in our daily operations.”

These projects will be presented in a Big Data and AI conference on 30 December.

 

Related Companies

Free Whitepaper
img

How is AI impacting the future of Healthcare?

The applications of AI in healthcare are many, with the potential to transform key aspects of the industry and drive innovation. Uses include data management, remote surgery, diagnostic and procedural AI assistants, drug discovery, and clinical trial design. GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019.

GlobalData’s AI in Healthcare Thematic Research report provides you with an in-depth lens into the impact of artificial intelligence on the industry. We highlight both the challenges and opportunities associated with the innovative technology now, and in the future. Our report also covers:

  • Major players and companies
  • Market size and growth forecasts
  • Case studies
  • Sector scorecard

According to our recent survey, almost two-thirds of pharma professionals expect AI to be the leading disruptive technology in the pharma sector over the next two years. With threats to the industry exacerbated by the COVID-19 pandemic, you should be proactive in adapting strategies and processes to help you remain competitive. Download the full report to get ahead of the competition.

by GlobalData
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management